Zai Lab (ZLAB) Long-Term Investments (2016 - 2024)
Zai Lab (ZLAB) posted Long-Term Investments of $3.1 million for Q4 2024, down 1.21% sequentially from $3.2 million in Q3 2024, and down 66.21% YoY from $9.2 million in Q1 2024.
Zai Lab (ZLAB) Long-Term Investments (2016 - 2024) Analysis & Trends
Zai Lab has reported Long-Term Investments for 9 years, with the latest figure at $3.1 million in Q4 2024.
- Quarterly Long-Term Investments fell 66.21% year-over-year to $3.1 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $3.1 million (down 66.21% YoY) and the FY2024 annual result came in at $3.1 million, down 66.21% from the prior year.
- Long-Term Investments eased to $3.1 million in Q4 2024 per ZLAB's latest filing, from $3.2 million in the prior quarter.
- Over five years, Long-Term Investments peaked at $20.8 million in Q3 2021 and troughed at $1.1 million in Q2 2021.
- A 5-year average of $6.3 million and a median of $4.3 million in 2023 frame the typical range for Long-Term Investments.
- The sharpest annual moves came in 2021 and 2022: Long-Term Investments surged 1120.09% in 2021, then sank 84.06% in 2022.
- Over 5 years, Long-Term Investments stood at $1.3 million in 2020, then soared by 1120.09% to $15.6 million in 2021, then plunged by 58.79% to $6.4 million in 2022, then jumped by 43.37% to $9.2 million in 2023, then plunged by 66.21% to $3.1 million in 2024.
- According to Business Quant data, Long-Term Investments over the past three periods registered $3.1 million, $3.2 million, and $4.1 million for Q4 2024, Q3 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3.12 Mn |
| Sep 30, 2024 | 3.15 Mn |
| Jun 30, 2024 | 4.07 Mn |
| Mar 31, 2024 | 14.11 Mn |
| Dec 31, 2023 | 9.22 Mn |
| Sep 30, 2023 | 4.47 Mn |
| Jun 30, 2023 | 5.13 Mn |
| Mar 31, 2023 | 6.87 Mn |
| Dec 31, 2022 | 6.43 Mn |
| Sep 30, 2022 | 3.32 Mn |
| Jun 30, 2022 | 2.83 Mn |
| Mar 31, 2022 | 8.44 Mn |
| Dec 31, 2021 | 15.61 Mn |
| Sep 30, 2021 | 20.80 Mn |
| Jun 30, 2021 | 1.07 Mn |
| Mar 31, 2021 | 1.47 Mn |
| Dec 31, 2020 | 1.28 Mn |
| Jun 30, 2020 | 1.99 Mn |
| Dec 31, 2019 | 2.40 Mn |
| Sep 30, 2019 | 2.65 Mn |